1. Home
  2. BREA vs CYCN Comparison

BREA vs CYCN Comparison

Compare BREA & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BREA
  • CYCN
  • Stock Information
  • Founded
  • BREA 2022
  • CYCN 2018
  • Country
  • BREA Ireland
  • CYCN United States
  • Employees
  • BREA N/A
  • CYCN N/A
  • Industry
  • BREA Services-Misc. Amusement & Recreation
  • CYCN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BREA Consumer Discretionary
  • CYCN Health Care
  • Exchange
  • BREA Nasdaq
  • CYCN Nasdaq
  • Market Cap
  • BREA 8.7M
  • CYCN 8.4M
  • IPO Year
  • BREA 2023
  • CYCN N/A
  • Fundamental
  • Price
  • BREA $0.63
  • CYCN $3.12
  • Analyst Decision
  • BREA
  • CYCN
  • Analyst Count
  • BREA 0
  • CYCN 0
  • Target Price
  • BREA N/A
  • CYCN N/A
  • AVG Volume (30 Days)
  • BREA 39.6K
  • CYCN 5.8M
  • Earning Date
  • BREA 01-03-2025
  • CYCN 03-04-2025
  • Dividend Yield
  • BREA N/A
  • CYCN N/A
  • EPS Growth
  • BREA N/A
  • CYCN N/A
  • EPS
  • BREA N/A
  • CYCN N/A
  • Revenue
  • BREA $2,872,101.00
  • CYCN $194,000.00
  • Revenue This Year
  • BREA N/A
  • CYCN N/A
  • Revenue Next Year
  • BREA N/A
  • CYCN N/A
  • P/E Ratio
  • BREA N/A
  • CYCN N/A
  • Revenue Growth
  • BREA 2338.69
  • CYCN N/A
  • 52 Week Low
  • BREA $0.50
  • CYCN $1.27
  • 52 Week High
  • BREA $2.44
  • CYCN $9.47
  • Technical
  • Relative Strength Index (RSI)
  • BREA 38.35
  • CYCN 46.78
  • Support Level
  • BREA $0.60
  • CYCN $2.81
  • Resistance Level
  • BREA $0.67
  • CYCN $4.80
  • Average True Range (ATR)
  • BREA 0.04
  • CYCN 0.76
  • MACD
  • BREA -0.01
  • CYCN -0.08
  • Stochastic Oscillator
  • BREA 13.91
  • CYCN 20.76

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: